These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 114594)

  • 1. A simple electrophoretic technique for the estimation of complement C3 conversion: specific application to the investigation of anaphylactoid response to I.V. agents.
    Strong R; Watkins J
    J Immunol Methods; 1979; 29(3):293-7. PubMed ID: 114594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Underlying immunopathology as a cause of adverse responses to two intravenous anaesthetic agents.
    Watkins J; Padfield A; Alderson JD
    Br Med J; 1978 May; 1(6121):1180-1. PubMed ID: 638678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of C3 and consumption of hemolytic complement by extracts of airborne grain dust.
    Olenchock SA; Mull JC; Major PC
    Chest; 1979 Feb; 75(2 Suppl):225-7. PubMed ID: 108049
    [No Abstract]   [Full Text] [Related]  

  • 4. [Complement activation after circulatory collapse with intravenous administration of alphaxolone/alphadolone (Althesin)].
    Olesen AS; Hüttel MS; Hansen SE
    Ugeskr Laeger; 1980 May; 142(21):1359-60. PubMed ID: 7404735
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
    Doherty M; Whicher JT; Dieppe PA
    Ann Rheum Dis; 1983 Jun; 42(3):285-91. PubMed ID: 6407405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylactoid reactions to i.v. substances.
    Watkins J
    Br J Anaesth; 1979 Jan; 51(1):51-60. PubMed ID: 399590
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of adverse reactions to althesin.
    Radford SG; Lockyer JA; Simpson PJ
    Br J Anaesth; 1982 Aug; 54(8):859-63. PubMed ID: 7104135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni.
    Ferrante A; Rowan-Kelly B
    Clin Exp Immunol; 1983 Nov; 54(2):477-85. PubMed ID: 6418422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple quantification of complement factors C3 and C3b using separation by isotachophoresis.
    Acevedo F
    Electrophoresis; 1999 Mar; 20(3):469-72. PubMed ID: 10217155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracts of airborne grain dusts activate alternative and classical complement pathways.
    Olenchock SA; Mull JC; Major PC
    Ann Allergy; 1980 Jan; 44(1):23-8. PubMed ID: 6766283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes.
    Leslie RG; Nielsen CH
    Immunology; 2004 Jan; 111(1):86-90. PubMed ID: 14678202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of immunofixation: detection and quantitation of complement activation.
    Whicher JT; Higginson J; Riches PG; Radford S
    J Clin Pathol; 1980 Aug; 33(8):781-5. PubMed ID: 6776155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B; Brandslund I; Grunnet N; Hansen LK; Thellesen J; Svehag SE
    J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of murine complement by cobra venom factor in the presence of EDTA.
    Goldman JN; Bangalore S; Goldman MB
    J Immunol; 1979 Nov; 123(5):2421-7. PubMed ID: 114590
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of the alternate pathway in chelated serum.
    Forsgren A; Mclean RH; Michael AF; Quie PG
    J Lab Clin Med; 1975 Jun; 85(6):904-12. PubMed ID: 805816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C3 proteins in psoriasis.
    Acevedo F; Hammar H
    Br J Dermatol; 1989 Sep; 121(3):329-35. PubMed ID: 2508741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propofol ('Diprivan') on histamine release, immunoglobulin levels and activation of complement in healthy volunteers.
    Doenicke A; Lorenz W; Stanworth D; Duka T; Glen JB
    Postgrad Med J; 1985; 61 Suppl 3():15-20. PubMed ID: 3877283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of specificity of the C3-opsonized zymosan reagent for the assay of membrane complement receptors.
    Egwang TG; Gauldie J; Befus AD
    J Immunol Methods; 1983 Jul; 61(2):253-7. PubMed ID: 6345679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.